PEPCK 1 Deficiency Latest Advances
Find the Latest Research About PEPCK 1 Deficiency
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications
Pck1 Deficiency Drives Mitochondrial Dysfunction and Cellular Senescence in Adipocytes.
Journal: Aging cell
Published: September 04, 2025
Transcriptional and epigenetic responses to acute hypoxia exposure in rainbow trout (Oncorhynchus mykiss).
Journal: Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology
Published: May 15, 2025
Cytosolic Phosphoenoylpyruvate Carboxykinase Deficiency: Clinical, Biochemical, and Genetic Features of Five Non-Finnish Patients.
Journal: American journal of medical genetics. Part A
Published: May 15, 2025
Notoginsenoside R1 Improved Hypoxic Pulmonary Hypertension by Inhibiting Glycolysis-Mediated Pulmonary Arterial Vascular Remodeling.
Journal: Canadian respiratory journal
Published: April 09, 2025
Decreased expression of insulin-degrading enzyme increases gluconeogenesis and glucose production in cultured hepatocytes administered with glucagon.
Journal: Scientific reports
Published: March 17, 2025
A Novel PCK1 Gene Variant Associated With Cytosolic Phosphoenolpyruvate Carboxykinase Deficiency: Two Siblings With Different Clinical Presentations.
Journal: JIMD reports
Published: February 27, 2025
PCK1 deficiency promotes MASH-HCC progression by 12-HETE-induced CD8+ T cell dysfunction.
Journal: Gut
Published: December 10, 2024
The neglected PCK1/glucagon (inter)action in nutrient homeostasis beyond gluconeogenesis: Disease pathogenesis and treatment.
Journal: Molecular metabolism
Published: November 30, 2024
Cytosolic PEPCK deficiency caused by a novel homozygous frame-shift variant presenting as resolved hypoglycemia and acute liver failure at birth.
Journal: Molecular genetics and metabolism reports
Published: October 02, 2024
Phosphoenolpyruvate carboxykinase 1-mediated cataplerosis is required to maintain mitochondrial fitness and to avoid kidney disease progression.
Journal: Kidney international
Published: September 09, 2024
Hepatocyte-specific RIG-I loss attenuates metabolic dysfunction-associated steatotic liver disease in mice via changes in mitochondrial respiration and metabolite profiles.
Journal: Toxicological research
Published: June 21, 2024
Last Updated: 04/28/2026